Virginie-Anne Chouinard, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Psychotic Disorders | 7 | 2022 | 3220 | 0.950 |
Why?
|
Substance Withdrawal Syndrome | 6 | 2024 | 625 | 0.830 |
Why?
|
Schizophrenia | 7 | 2019 | 6929 | 0.640 |
Why?
|
Bipolar Disorder | 6 | 2019 | 5091 | 0.640 |
Why?
|
Suicide, Attempted | 2 | 2019 | 1402 | 0.620 |
Why?
|
Siblings | 3 | 2018 | 824 | 0.570 |
Why?
|
Psychoses, Substance-Induced | 4 | 2017 | 99 | 0.560 |
Why?
|
Hallucinations | 1 | 2019 | 366 | 0.530 |
Why?
|
Antipsychotic Agents | 5 | 2023 | 3066 | 0.350 |
Why?
|
Frontal Lobe | 1 | 2017 | 1418 | 0.350 |
Why?
|
Interview, Psychological | 3 | 2024 | 809 | 0.320 |
Why?
|
Iatrogenic Disease | 2 | 2010 | 538 | 0.300 |
Why?
|
Akathisia, Drug-Induced | 1 | 2008 | 67 | 0.300 |
Why?
|
Dyskinesia, Drug-Induced | 2 | 2023 | 165 | 0.300 |
Why?
|
Magnetic Resonance Spectroscopy | 2 | 2017 | 3769 | 0.290 |
Why?
|
Overweight | 1 | 2016 | 2417 | 0.230 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 4 | 2024 | 1988 | 0.220 |
Why?
|
Insulin | 1 | 2018 | 6593 | 0.220 |
Why?
|
Depressive Disorder, Major | 3 | 2016 | 4764 | 0.200 |
Why?
|
Body Mass Index | 2 | 2018 | 12943 | 0.190 |
Why?
|
Parkinsonian Disorders | 1 | 2023 | 285 | 0.180 |
Why?
|
Dystonia | 1 | 2023 | 370 | 0.170 |
Why?
|
Movement Disorders | 1 | 2023 | 459 | 0.170 |
Why?
|
Visual Perception | 2 | 2019 | 1388 | 0.170 |
Why?
|
Optical Illusions | 1 | 2017 | 40 | 0.140 |
Why?
|
Phosphorus Isotopes | 1 | 2017 | 124 | 0.140 |
Why?
|
Mental Disorders | 3 | 2024 | 6826 | 0.140 |
Why?
|
Antidepressive Agents | 2 | 2023 | 2896 | 0.140 |
Why?
|
Adrenergic Uptake Inhibitors | 1 | 2018 | 186 | 0.140 |
Why?
|
Phosphocreatine | 1 | 2017 | 261 | 0.130 |
Why?
|
Catatonia | 1 | 2019 | 178 | 0.130 |
Why?
|
Bereavement | 2 | 2010 | 309 | 0.130 |
Why?
|
Hydrogen-Ion Concentration | 2 | 2018 | 2495 | 0.130 |
Why?
|
Psychiatric Status Rating Scales | 4 | 2022 | 6016 | 0.120 |
Why?
|
Creatine Kinase | 1 | 2017 | 685 | 0.120 |
Why?
|
Prevalence | 4 | 2019 | 15689 | 0.120 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2018 | 12142 | 0.110 |
Why?
|
Depressive Disorder | 2 | 2023 | 3735 | 0.110 |
Why?
|
Anthropometry | 1 | 2018 | 1338 | 0.110 |
Why?
|
NAD | 1 | 2017 | 614 | 0.100 |
Why?
|
Lactic Acid | 1 | 2018 | 1139 | 0.100 |
Why?
|
Anxiety Disorders | 2 | 2014 | 2723 | 0.100 |
Why?
|
Psychotropic Drugs | 1 | 2017 | 888 | 0.090 |
Why?
|
Oxidation-Reduction | 1 | 2017 | 2231 | 0.090 |
Why?
|
Adenosine Triphosphate | 1 | 2017 | 1988 | 0.090 |
Why?
|
Triglycerides | 1 | 2018 | 2459 | 0.090 |
Why?
|
Dopamine | 1 | 2017 | 1606 | 0.090 |
Why?
|
Cross-Sectional Studies | 4 | 2019 | 26049 | 0.090 |
Why?
|
Leptin | 1 | 2018 | 1595 | 0.080 |
Why?
|
Body Composition | 1 | 2018 | 2426 | 0.080 |
Why?
|
Adult | 12 | 2024 | 220969 | 0.080 |
Why?
|
Brain | 6 | 2018 | 27101 | 0.070 |
Why?
|
Life Change Events | 2 | 2010 | 952 | 0.070 |
Why?
|
Humans | 29 | 2024 | 760617 | 0.070 |
Why?
|
Cognition Disorders | 2 | 2012 | 3979 | 0.070 |
Why?
|
Glucose | 1 | 2018 | 4345 | 0.070 |
Why?
|
Male | 15 | 2024 | 360358 | 0.060 |
Why?
|
Mood Disorders | 1 | 2012 | 1127 | 0.060 |
Why?
|
Comorbidity | 3 | 2016 | 10505 | 0.060 |
Why?
|
Family | 2 | 2014 | 3193 | 0.060 |
Why?
|
Twin Studies as Topic | 1 | 2005 | 103 | 0.060 |
Why?
|
Pancreas Transplantation | 1 | 2005 | 197 | 0.060 |
Why?
|
Female | 14 | 2024 | 392148 | 0.060 |
Why?
|
Ambulatory Care | 1 | 2015 | 2768 | 0.060 |
Why?
|
Insulin Resistance | 1 | 2018 | 3954 | 0.060 |
Why?
|
Autoantibodies | 1 | 2012 | 2115 | 0.050 |
Why?
|
Blood Glucose | 1 | 2018 | 6390 | 0.050 |
Why?
|
Reproducibility of Results | 4 | 2023 | 20074 | 0.050 |
Why?
|
Tacrolimus | 1 | 2005 | 733 | 0.050 |
Why?
|
Reaction Time | 1 | 2008 | 2087 | 0.050 |
Why?
|
Psychomotor Agitation | 1 | 2023 | 305 | 0.050 |
Why?
|
Huntington Disease | 1 | 2008 | 1144 | 0.050 |
Why?
|
Anticonvulsants | 1 | 2010 | 1906 | 0.040 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 2 | 2005 | 3708 | 0.040 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 2012 | 2152 | 0.040 |
Why?
|
Multicenter Studies as Topic | 1 | 2023 | 1700 | 0.040 |
Why?
|
Attention | 1 | 2008 | 2396 | 0.040 |
Why?
|
Illusions | 1 | 2017 | 61 | 0.030 |
Why?
|
Young Adult | 3 | 2017 | 59179 | 0.030 |
Why?
|
Norepinephrine | 1 | 2018 | 898 | 0.030 |
Why?
|
Adolescent | 4 | 2017 | 88234 | 0.030 |
Why?
|
Signal Transduction | 1 | 2018 | 23416 | 0.030 |
Why?
|
Receptors, Dopamine D2 | 1 | 2017 | 484 | 0.030 |
Why?
|
Social Work | 1 | 2015 | 158 | 0.030 |
Why?
|
Middle Aged | 6 | 2024 | 220584 | 0.030 |
Why?
|
Obesity | 1 | 2016 | 12933 | 0.030 |
Why?
|
Patient Dropouts | 1 | 2015 | 410 | 0.030 |
Why?
|
Social Adjustment | 1 | 2015 | 632 | 0.030 |
Why?
|
Serotonin | 1 | 2018 | 1041 | 0.030 |
Why?
|
Endophenotypes | 1 | 2014 | 255 | 0.030 |
Why?
|
Chronic Disease | 1 | 2008 | 9311 | 0.030 |
Why?
|
Observer Variation | 1 | 2018 | 2606 | 0.020 |
Why?
|
Neuropsychological Tests | 3 | 2012 | 7050 | 0.020 |
Why?
|
Case-Control Studies | 3 | 2017 | 22148 | 0.020 |
Why?
|
Photic Stimulation | 1 | 2017 | 1987 | 0.020 |
Why?
|
Kidney Transplantation | 1 | 2005 | 4236 | 0.020 |
Why?
|
Outpatients | 1 | 2018 | 1596 | 0.020 |
Why?
|
Incidence | 1 | 2008 | 21337 | 0.020 |
Why?
|
Aging | 1 | 2008 | 8699 | 0.020 |
Why?
|
Regional Blood Flow | 1 | 2012 | 1496 | 0.020 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 2012 | 1068 | 0.020 |
Why?
|
Diagnosis, Differential | 2 | 2015 | 12966 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2022 | 14648 | 0.020 |
Why?
|
Alzheimer Disease | 1 | 2008 | 8601 | 0.020 |
Why?
|
Energy Metabolism | 1 | 2017 | 2878 | 0.020 |
Why?
|
Receptors, Dopamine D5 | 1 | 2005 | 32 | 0.020 |
Why?
|
Delivery of Health Care | 1 | 2023 | 5332 | 0.020 |
Why?
|
Adoption | 1 | 2005 | 97 | 0.020 |
Why?
|
Receptors, Glutamate | 1 | 2005 | 227 | 0.010 |
Why?
|
Patient Care Team | 1 | 2015 | 2515 | 0.010 |
Why?
|
Diffusion Tensor Imaging | 1 | 2014 | 2400 | 0.010 |
Why?
|
Facial Expression | 1 | 2008 | 508 | 0.010 |
Why?
|
Receptors, Dopamine D1 | 1 | 2005 | 292 | 0.010 |
Why?
|
Attention Deficit and Disruptive Behavior Disorders | 1 | 2005 | 306 | 0.010 |
Why?
|
Selection Bias | 1 | 2005 | 359 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2005 | 17878 | 0.010 |
Why?
|
Massachusetts | 1 | 2015 | 8833 | 0.010 |
Why?
|
Problem Solving | 1 | 2005 | 444 | 0.010 |
Why?
|
Depression | 1 | 2022 | 8132 | 0.010 |
Why?
|
Molecular Biology | 1 | 2005 | 575 | 0.010 |
Why?
|
Self Report | 1 | 2012 | 3723 | 0.010 |
Why?
|
Severity of Illness Index | 2 | 2009 | 15828 | 0.010 |
Why?
|
Internet | 1 | 2012 | 3090 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 2010 | 6305 | 0.010 |
Why?
|
Psychometrics | 1 | 2009 | 3060 | 0.010 |
Why?
|
Evoked Potentials | 1 | 2005 | 1047 | 0.010 |
Why?
|
Substance-Related Disorders | 1 | 2015 | 4416 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2012 | 12043 | 0.010 |
Why?
|
Suicide | 1 | 2009 | 1601 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2010 | 10754 | 0.010 |
Why?
|
Patient Selection | 1 | 2009 | 4237 | 0.010 |
Why?
|
Nerve Net | 1 | 2008 | 2290 | 0.010 |
Why?
|
Cognition | 1 | 2012 | 6987 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2015 | 39063 | 0.010 |
Why?
|
Risk Factors | 2 | 2010 | 74115 | 0.010 |
Why?
|
Graft Rejection | 1 | 2005 | 4446 | 0.010 |
Why?
|
Referral and Consultation | 1 | 2005 | 3599 | 0.010 |
Why?
|
Sex Factors | 1 | 2005 | 10548 | 0.010 |
Why?
|
Diagnostic Imaging | 1 | 2005 | 3527 | 0.010 |
Why?
|
Time Factors | 1 | 2008 | 39913 | 0.000 |
Why?
|
Prospective Studies | 1 | 2009 | 54360 | 0.000 |
Why?
|
Child | 1 | 2005 | 80079 | 0.000 |
Why?
|